Augmedix, Inc.
NASDAQ:AUGX
2.345 (USD) • At close October 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 44.855 | 30.933 | 22.165 | 16.483 | 14.108 | 10.815 |
| Cost of Revenue
| 23.329 | 16.979 | 12.158 | 9.689 | 9.428 | 10.029 |
| Gross Profit
| 21.526 | 13.954 | 10.007 | 6.794 | 4.679 | 0.786 |
| Gross Profit Ratio
| 0.48 | 0.451 | 0.451 | 0.412 | 0.332 | 0.073 |
| Reseach & Development Expenses
| 11.176 | 10.149 | 6.678 | 4.522 | 6.977 | 6.961 |
| General & Administrative Expenses
| 18.442 | 16.893 | 13.759 | 11.567 | 10.861 | 13.154 |
| Selling & Marketing Expenses
| 10.687 | 9.283 | 7.508 | 4.398 | 3.583 | 3.594 |
| SG&A
| 29.129 | 26.176 | 21.267 | 15.965 | 14.445 | 16.748 |
| Other Expenses
| 1.001 | -2.078 | 0.087 | -1.911 | 1.05 | 0 |
| Operating Expenses
| 40.305 | 36.325 | 27.945 | 20.487 | 21.422 | 22.87 |
| Operating Income
| -18.779 | -22.371 | -17.938 | -13.693 | -16.743 | -22.922 |
| Operating Income Ratio
| -0.419 | -0.723 | -0.809 | -0.831 | -1.187 | -2.119 |
| Total Other Income Expenses Net
| -0.247 | -1.967 | 0.134 | -1.911 | -1.756 | -1.24 |
| Income Before Tax
| -19.026 | -24.449 | -17.851 | -15.604 | -18.498 | -24.163 |
| Income Before Tax Ratio
| -0.424 | -0.79 | -0.805 | -0.947 | -1.311 | -2.234 |
| Income Tax Expense
| 0.145 | 2.078 | -0.691 | -0.867 | 3.863 | 0 |
| Net Income
| -19.171 | -26.527 | -17.16 | -14.737 | -22.361 | -24.163 |
| Net Income Ratio
| -0.427 | -0.858 | -0.774 | -0.894 | -1.585 | -2.234 |
| EPS
| -0.44 | -0.71 | -0.59 | -2.1 | -26.89 | -20.32 |
| EPS Diluted
| -0.44 | -0.71 | -0.59 | -2.1 | -26.89 | -20.32 |
| EBITDA
| -17.681 | -21.807 | -14.474 | -12.825 | -14.737 | -21.334 |
| EBITDA Ratio
| -0.394 | -0.723 | -0.809 | -0.831 | -1.045 | -1.973 |